Brain Cancer: Research
The question
To ask the Secretary of State for Health and Social Care, what progress his Department has made on allocating funding to brain cancer research.
Answered by Andrew Gwynne
Research is crucial in tackling cancer, which is why the Department invests over £1.5 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23. The NIHR spends more on cancer than any other disease group, reflecting its high priority. We are committed to furthering our investment and support for high-quality brain tumour research.
In the five years between 2018/19 and 2022/23, the NIHR directly invested £11.3 million in research projects and programmes focused on brain tumours across 15 awards. In addition, our wider investments in NIHR research infrastructure, including facilities, services, and the research workforce, are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period. In total NIHR investments have enabled 8,500 people to participate in potentially life-changing research in the National Health Service over this time.
In September 2024, the NIHR launched new funding opportunities for a Brain Cancer Research Consortium and a major new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →